Abstract
The D327N mutation of human SHBG is associated with a number of good prognostic factors in breast cancer like estrogen receptor positivity and erb2 negativity. The identification of this mutation, that requires only a small sample of circulating blood, could be helpful whenever tissue samples are too scanty for the determination of prognostic factors, e.g. at fine needle aspiration for cytology. The search for this mutation is routinely performed in our laboratory with the HinfI restriction fragment length polymorphism (RFLP) technique on polymerase chain reaction (PCR)-amplified DNA. The present report describes a new and simple enzyme-linked immunosorbent assay (ELISA) method to detect the SHBG mutation. The DNA enzyme immuno assay (DEIA) method, that is widely used in virology and has already been used to identify single nucleotide mutations, allows the identification of hybrids between specific DNA sequences and biotynilated probes with a monoclonal antibody against double stranded-DNA. We here report that by using two specific probes, specifically built for this kind of test, one complementary to the wild type SHBG sequence and the other to the D327N mutated DNA, the DEIA technique can be used to identify on PCR-amplified DNA the D327N mutation of human SHBG exactly as the HinfI RFLP technique. The DEIA technique could, thus, be especially helpful when a large number of samples has to be processed, the technique being easier than HinfI RFLP, specific, reproducible and allowing substantial time saving.
Similar content being viewed by others
References
Hammond GL. Potential functions of plasma steroid-binding proteins. Trends Endocrinol Metab 1995, 6: 298–304.
Fortunati N, Fissore F, Fazzari A, et al. Sex steroid binding protein (SBP, SHBG) exerts a negative control on estradiol action in MCF-7 cells (human breast cancer) through cAMP and PKA. Effect on estradiol-induced cell proliferation. Endocrinology 1996, 137: 686–92.
Raineri M, Catalano MG, Hammond GL, Avvakumov GV, Frairia R, Fortunati N. O-glycosylation of human sex hormone-binding globulin is essential for inhibition of estradiol- induced MCF-7 breast cancer cell proliferation. Mol Cell Endocrinol 2002, 189: 135–43.
Power SGA, Bocchinfuso WP, Pallesen M, Warmels-Rodenhiser S, Van Baelen H, Hammond GL. Molecular analyses of a human sex hormone-binding globulin variant: evidence for an additional carbohydrate chain. J Clin Endocrinol Metab 1992, 75: 1066–70.
Forsti A, Jin Q, Grzybowska E, et al. Sex hormone-binding globulin polymorphisms in familial and sporadic breast cancer. Carcinogenesis 2002, 23: 1315–20.
Becchis M, Frairia R, Ferrera P, et al. The additionally glycosylated variant of human sex hormone-binding globulin (SHBG) is linked to estrogen-dependence of breast cancer. Breast Cancer Res Treat 1999, 54: 101–7.
Fortunati N, Biglia N, Cozzarella M, Boccuzzi G, Sismondi P, Frairia R. The D327N variant of human sex hormone-binding globulin (SHBG) is a new favourable prognostic factor in breast cancer. Breast Cancer Res, submitted in 2003.
Lahiri DK, Nurnberger JI Jr. A rapid non-enzymatic method for the preparation of HMW-DNA from blood for RFLP studies. Nucleic Acid Res 1991, 19: 5444.
Imberti L, Sottini A, Bettinardi A, Mazza C, Alberini A, Primi D. Non-radioisotopic methods for DNA probes. Ann Biol Clin 1992, 50: 163–7.
Mantero G, Zonaro A, Alberini A, Bertolo P, Primi D. DNA enzyme immunoassay: general method for detecting products of polymerase chain reaction. Clin Chem 1991, 37: 422–9.
Sangiuolo F, De Santis L, Cavicchini A, et al. A new method for direct analysis of polymerase chain reaction-amplified human papillomavirus using DNA enzyme immunoassay. Int J Clin Lab Res 1994, 24: 223–6.
Dinolfo L, Abate ML, Bertolo P, et al. Detection of hepatitis D virus RNA in serum by a reverse trascription polymerase chain reaction-based assay. Int J Clin Lab Res 1995, 25: 35–9.
Magalini AR, Primi D, Albertini A, Capucci A, Rossi G, Mantero G. Detection of BCR/ABL transcripts in chronic myeloid leucemia by polymerase chain reaction and DNA enzyme immunoassay: a DNA probe assay without DNA labelling. Br J Haematol 1993, 83: 334–9.
Mazza C, Mantero G, Primi D. DNA enzyme immunoassay: a rapid and convenient colorimetric method for diagnosis of cystic fibrosis. Mol Cell Probes 1991, 5: 459–66.
Tosi G, Mantero G, Magalini AR, et al. HLA-DQB1 typing of North East Italian IDDM population using amplified DNA, oligonucleotide probes and a rapid DNA-enzyme immunoassay (DEIA). Mol Immunol 1993, 30: 69–76.
Prati D, Rawal BD, Dang C, Capelli C, Vyas GN. DNA enzyme immunoassay for the PCR-amplified HLA-DQ alpha gene for estimating residual leokocytes in filtered blood. Clin Diagn Lab Immunol 1995, 3: 182–5.
Irani-Hakime N, Tamim H, Elias G, et al. Factor V R506Q mutation-Leiden: an indipendent risk factor for venous thrombosis but not coronary artery disease. J Thromb Thrombolysis 2001, 11: 111–6.
Cousin P, De Chaud H, Grenot C, Lejeune H, Pugeat M. with the technical assistence of Baret C. and Brébant C. Human variant Sex Hormone-Binding Globulin (SHBG) with an additional carbohydrate chain has a reduced clearance rate in rabbit. J Clin Endocrinol Metab 1998, 83: 235–40.
Hogeveen KN, Cousin P, Pugeat M, Dewailly D, Soudan B, Hammond GL. Human sex hormone-binding globulin variants associated with hyperandrogenism and ovarian dysfunction. J Clin Invest 2002, 109: 973–81.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fortunati, N., Frairia, R. A new ELISA method to identify the D327N mutation of human sex hormone binding globulin (SHBG). J Endocrinol Invest 26, 1100–1104 (2003). https://doi.org/10.1007/BF03345257
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345257